Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
11.04. | Soligenix Granted FDA Orphan Drug Designation for SuVax Active Ingredient | ||
10.04. | Sen-Jam Pharmaceutical Enters Strategic Partnership with KVK-Tech | ||
10.04. | AdrenoMed's Enibarcimab Fast Tracked for Septic Shock | ||
10.04. | NorthStar Medical Radioisotopes Enters Clinical Supply Pact | ||
10.04. | Ginkgo Bioworks, Novo Nordisk Expand R&D Alliance | ||
10.04. | Oculis Names Dr. Snehal Shah as President of R&D | ||
10.04. | EUROAPI Reorganizes Executive Leadership | ||
10.04. | Batavia, Chromatan Receive NIIMBL Grant to Improve AAV Manufacturing | ||
10.04. | Sartorius Partners with TheWell Bioscience for Animal-Free Hydrogels & Bioinks | ||
09.04. | Bios Health Group Introduces Bios Innovation Circle | ||
09.04. | Essential Pharma Acquires Renaissance Pharma | ||
09.04. | Waters Corporation Introduces Alliance iS BioHPLC System | ||
09.04. | Basilea Awarded CARB-X Grant to Develop Antibiotics | ||
09.04. | Lonza, NeuroSense Enter Alliance for ALS Candidate | ||
09.04. | Ascend Acquires Florida Facility and Expertise, Bolstering Gene Therapy Development | ||
09.04. | AskBio Names Dr. Mansuo Shannon as Chief Scientific Officer | ||
09.04. | Xencor Names Bart Cornelissen as SVP and Chief Financial Officer | ||
09.04. | CoreRx Completes Acquisition of Societal CDMO | ||
09.04. | Charles River & Axovia Partner to Support Development of Gene Therapies for Ciliopathies | ||
08.04. | MilliporeSigma Invests €300M in New Bioprocessing Facility in South Korea | ||
08.04. | AustinPx Enhances Early Phase Development & Manufacturing Capabilities | ||
08.04. | Dizal's Sunvozertinib Granted Breakthrough Therapy Designation | ||
08.04. | Zura Bio Names Robert Lisicki as CEO & Director of the Board | ||
08.04. | Pluri Unveils Proprietary 3D Cell Expansion Technology | ||
08.04. | Ayana Pharma Signs Master Service Agreement with Scinai Immunotherapeutics |